cookies to track usage and preferences."
data-cookieaccepttext="I UNDERSTAND"
data-cookiedeclinetext="Disable Cookies"
data-cookiepolicytext="Privacy Policy">
Genetic conditions like Dravet syndrome, which causes severe childhood epilepsy, are hard to tackle with traditional gene therapy. New approaches in the works include using antisense therapy to boost mRNA splicing.
A gaggle of biotech start-ups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. It’s too early to know which, if any, will succeed.
Close X
This is not a paywall.
Knowable Magazine is free to read. But just because our articles are free to read doesn’t mean they are free to produce. If you value our trustworthy science journalism, please support it with a donation.
